<i>Cannabis sativa</i> L.: Crop Management and Abiotic Factors That Affect Phytocannabinoid Production

The main characteristic of <i>Cannabis sativa</i> L. is the production of compounds of medicinal interest known as phytocannabinoids. Environmental factors and crop management practices are directly related to the yield of these compounds. Knowing how these factors influence the producti...

Full description

Bibliographic Details
Published in:	Agronomy
Main Authors:	Ingrid Trancoso, Guilherme A. R. de Souza, Paulo Ricardo dos Santos, Késia Dias dos Santos, Rosana Maria dos Santos Nani de Miranda, Amanda Lúcia Pereira Machado da Silva, Dennys Zsolt Santos, Ivan F. García-Tejero, Eliemar Campostrini
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Subjects:	<i>Cannabis sativa</i> crop management CBD THC hemp marijuana
Online Access:	https://www.mdpi.com/2073-4395/12/7/1492

Similar Items

Differentiating Cannabis Products: Drugs, Food, and Supplements
by: Arash Salehi, et al.
Published: (2022-06-01)

Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey
by: Jamie Corroon, et al.
Published: (2019-12-01)

Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
by: Eric P. Baron, et al.
Published: (2018-05-01)

The Effect of Harvest Date on Temporal Cannabinoid and Biomass Production in the Floral Hemp (<i>Cannabis sativa</i> L.) Cultivars BaOx and Cherry Wine
by: Eric R. Linder, et al.
Published: (2022-10-01)

Online survey of medicinal cannabis users: Qualitative analysis of patient-level data
by: Albert Garcia-Romeu, et al.
Published: (2022-09-01)

Legal <i>Cannabis sativa</i> L. Dried Inflorescences: Cannabinoids Content and Cytotoxic Activity against Human HepG2 Cell Line
by: Maria Assunta Acquavia, et al.
Published: (2023-04-01)

“When you mix the best of high society with the best of high society”: culinary cannabis and the US hospitality industry
by: Alana N Seaman
Published: (2022-05-01)

The roles of cannabis potency and gender in cannabis dependence and anxiety in recent cannabis users with trauma exposure histories
by: T. Snooks, et al.
Published: (2025-02-01)

Evaluating Growth, Biomass and Cannabinoid Profiles of Floral Hemp Varieties under Different Planting Dates in Organic Soils of Florida
by: Saroop S. Sandhu, et al.
Published: (2022-11-01)

Monitoring Cannabinoids and the Safety of the Trace Element Profile of Light <i>Cannabis sativa</i> L. from Different Varieties and Geographical Origin
by: Vincenzo Nava, et al.
Published: (2022-12-01)

Sociodemographic characteristics and correlates of Delta-8 THC use in US adults
by: O. Livne
Published: (2022-06-01)

Legalization of marijuana or not? Opinions from over 38,000 residents in Taiwan
by: Kuo-Yu Chao, et al.
Published: (2023-10-01)

A comparative phytocannabinoid profiling of resin from five hemp (Cannabis sativa L.) cultivars from central-northern Morocco
by: Ismail El Bakali, et al.
Published: (2025-09-01)

Systematics and Botanical Characteristics of Industrial Hemp Cannabis Sativa L
by: Malgorzata Strzelczyk, et al.
Published: (2022-12-01)

Use of non-medical cannabis in epilepsy: A scoping review
by: Jimmy Li, et al.
Published: (2023-03-01)

<i>Cannabis</i>-Based Oral Formulations for Medical Purposes: Preparation, Quality and Stability
by: Francesca Baratta, et al.
Published: (2021-02-01)

<i>Cannabis</i>-Based Oral Emulsion for Medical Purposes to Meet the Needs of Patients: Formulation, Quality and Stability
by: Francesca Baratta, et al.
Published: (2022-02-01)

Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial
by: Sukpiriyagul A, et al.
Published: (2023-08-01)

Medical Cannabis in Pediatric Oncology: Friend or Foe?
by: Megan Malach, et al.
Published: (2022-03-01)

The Desert Whale: the boom and bust of hemp in Arizona
by: Anastasia K. Stats, et al.
Published: (2023-06-01)

Beyond Cannabidiol: The Contribution of <i>Cannabis sativa</i> Phytocomplex to Skin Anti-Inflammatory Activity in Human Skin Keratinocytes
by: Marco Fumagalli, et al.
Published: (2025-04-01)

Medical Cannabis in Children
by: Adi Aran, et al.
Published: (2020-01-01)

Cannabis and the Anxiety of Fragmentation—A Systems Approach for Finding an Anxiolytic Cannabis Chemotype
by: Brishna S. Kamal, et al.
Published: (2018-10-01)

Liquid Chromatography-Mass Spectrometry for the Geographical Sourcing of Cannabis sativa L.
by: Mariana Fernandes Ramos, et al.
Published: (2025-06-01)

Characterization of Nutrient Disorders of <i>Cannabis sativa</i>
by: Paul Cockson, et al.
Published: (2019-10-01)

Biological Activity of <i>Cannabis sativa</i> L. Extracts Critically Depends on Solvent Polarity and Decarboxylation
by: Guillermo Moreno-Sanz, et al.
Published: (2020-10-01)

Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends
by: Xintian Lyu, BS, et al.
Published: (2023-01-01)

Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties
by: Lara Sharpe, et al.
Published: (2020-10-01)

Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
by: Ana M. Martins, et al.
Published: (2022-02-01)

Development of a liquid chromatographic method with a different selectivity for the quantification of eighteen phytocannabinoids in hemp
by: Liguo Song, et al.
Published: (2024-12-01)

Impact of N, P, K, and Humic Acid Supplementation on the Chemical Profile of Medical Cannabis (Cannabis sativa L)
by: Nirit Bernstein, et al.
Published: (2019-06-01)

Oral Cannabis consumption and intraperitoneal THC:CBD dosing results in changes in brain and plasma neurochemicals and endocannabinoids in mice
by: Nichole Reisdorph, et al.
Published: (2024-03-01)

Case report: Treatment of non-medical tetrahydrocannabinol toxicosis with transmucosal cannabidiol-infused dissolving sheets in six dogs
by: Kyra Marsigliano, et al.
Published: (2024-12-01)

Implications of marijuana use prior to anesthetic care.
by: K. Stone, et al.
Published: (2023-01-01)

Editorial: Cannabis and cannabinoids in psychiatry
by: Pooja R. Sarkar, et al.
Published: (2025-05-01)

Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial
by: Erin L. Martin, et al.
Published: (2021-09-01)

Intraperitoneal delivery of cannabidiol (CBD) and Δ9-tetrahydocannabinol (THC) promotes papillomavirus infections in athymic nude mice
by: Sarah A. Brendle, et al.
Published: (2025-06-01)

An Overview of the Potential for Pharmacokinetic Interactions Between Drugs and Cannabis Products in Humans
by: Dolly Andrea Caicedo, et al.
Published: (2025-03-01)

Cannabis for Neuropathic Pain in Multiple Sclerosis—High Expectations, Poor Data
by: Thorsten Rudroff, et al.
Published: (2019-10-01)

The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms
by: Fatma Haddad, et al.
Published: (2022-05-01)